News
A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea - Gut
Methods 120 patients meeting Rome III criteria for IBS-D entered a randomised, double-blind, placebo-controlled crossover study of 5 weeks of ondansetron 4 mg versus placebo with dose titration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback